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Abstract 
Background: With the substantial growth over the past few years of available data on G 
Protein-Coupled Receptor (GPCR) dimers/oligomers, the need for an effective system to 
organize this information electronically has never been greater. Based on an ontology 
derived from a community dialog involving experimental and computational colleagues, 
we developed the GPCR-Oligomerization Knowledge Base (GPCR-OKB). 
 
Description: GPCR-OKB is an information system that supports browsing and searching 
for information about GPCR oligomers. The system offers information manually 
extracted from the literature, and curated according to the previously described GPCR-
OKB ontology. GPCR-OKB is seamlessly connected to GPCR-DB, facilitating 
navigation back and forth between information about GPCR protomers and oligomers.  
 
Conclusions: The GPCR-OKB system provides both experimental and computational 
information about GPCR oligomerization. Through data added regularly, GPCR-OKB is 
intended to support productive interactions between computational and experimental 
scientists working in the GPCR oligomerization field. This information system is freely 
accessible at http://www.gpcr-okb.org. 
Background 
G Protein-Coupled Receptors (GPCRs) are transmembrane (TM) helical proteins that 
transduce signals from the exterior to the interior of the cell via G-protein dependent and 
independent pathways [1]. Since they are the largest family of membrane proteins in 
mammalian genomes, and are implicated in many biological responses [2], it is not 
surprising that GPCRs also constitute the largest family of membrane protein targets for 
therapeutic compounds [3]. Although still a matter of controversy for some GPCR 
subtypes, the very close proximity of two or more receptors has been demonstrated 
unambiguously in artificial cell systems for several GPCRs using biochemical and 
biophysical techniques [4, 5]. The challenge now is to demonstrate that the majority of 
these receptor complexes exist and have functional significance in native tissue, although 
this information is already available for a few pairs [6].  
Information supporting the existence of functionally relevant GPCR dimers/oligomers is 
described in multiple articles published in different journals. This creates a challenge to 
the researcher who is trying to gather experimental evidence and/or computational 
predictions about any given oligomer.  Our previous work focused on the design of an 
ontology [7] to organize information about GPCR oligomerization, and its functional 
consequences in vitro and in vivo. The ontology was well received [8], demonstrating 
significant interest in an electronic system to access GPCR oligomer information. In this 
manuscript, we describe the GPCR-OKB system, which implements the GPCR-OKB 
ontology and an electronic front-end to information curated from more than 160 
published articles (as of January 2010).  
Construction and Content 
We developed the GPCR-OKB system to store both experimental and computational 
information about GPCR oligomerization. This information is publicly accessible at 
http://www.gpcr-okb.org. The GPCR-OKB system supports both browsing and 
structured searches.  
 
Content  
The content provided in GPCR-OKB was extracted from 164 Pubmed articles published 
mainly during the past decade, and was recorded in the database as close to the raw 
experimental data as possible to preserve objectivity. For this reason, only original 
research papers were annotated; review articles were excluded from curation. The latter, 
however, were checked to ensure that data from referenced original research articles were 
included in GPCR-OKB. Information was organized according to the GPCR-OKB 
ontology [7].  
 
Information captured 
From the 164 articles processed, we extracted information about 125 GPCR oligomers. 
Information pertaining to the physiological relevance or to the in vivo existence of the 
oligomer, as well as details about phenotypic changes, proposed oligomerization 
interfaces, proposed activation mechanisms, discovery/characterization methods, and cell 
types were considered for inclusion into the GPCR-OKB system. Figure 1 presents the 
broad types of information captured, and the relationships between them. These 
relationships are conveyed through web navigation in GPCR-OKB.  
 
Software implementation 
Web application. The GPCR-OKB web application was developed with the Grails web 
application framework. Information is stored in XML files that follow the GPCR-OKB 
XML schema (see http://www.gpcr-okb.org ->The Ontology ->Schema).  The XML 
Schema was designed in agreement with the GPCR-OKB ontology [7]. XML files are 
versioned with a subversion source control system. The GPCR-OKB web application 
loads these XML files at startup, indexes text fields, and starts serving web pages.    
 
Links with GPCR-DB. Data are exchanged between GPCR-DB [9] and GPCR-OKB to 
automate the creation of bidirectional navigation links. GPCR-DB exports information 
about protomers, which is loaded into GPCR-OKB. GPCR-OKB exports data about 
oligomers. All data exchanges are done in the XML format with an agreed upon XML 
schema.  
 
Utility  
The GPCR-OKB web user interface is organized around a gray navigation bar located at 
the top of each page. This navigation bar provides the “Home”, “Browse”, 
“Contributors”, “Disclaimer”, and “Help” categories (see Figure 2). Scroll down menus 
are located under these broad categories.  An item called “Locating data” is provided 
under “Help”, and provides quick pointers to help new users find their way around the 
system. “Abbreviations”, “Glossary” terms, and Frequently Asked Questions” can also be 
found under “Help”. 
 
Locating Data 
The information contained in GPCR-OKB can be browsed starting from any of the 
following concepts: “Oligomers”, “Protomers”, “Methods”, “Phenotypic Changes”, 
and/or “Evidence for Physiological Relevance”. For simplicity, GPCR-OKB only refers 
to GPCR oligomers, although the majority of published experimental studies cannot 
discriminate between dimers, tetramers, or higher-order oligomers. The “Search” tool at 
the top right side of each page (see Fig. 2) provides keyword searches across different 
types of information.  
 
Search Tool  
The Search tool is initially configured to search only oligomers. Selecting additional 
check boxes will also search protomers, methods, or restrict oligomer searches to specific 
types of oligomers. The “Question mark” icons are clickable to provide additional 
information about what the different options mean and how to use them. To search for a 
specific oligomer, the user specifies in the input box the name of the oligomer’s 
constituent protomers. For instance, if users are interested in retrieving information about 
an oligomer of the dopamine D2 receptor, they could enter "dopamine" or "D2" in the 
search box. Of note, GPCR-OKB searches are case-insensitive, and support the usual 
boolean operators (e.g., “and”, “or”, “not”) as well as advanced options, such as 
searching by regular expression. 
 
Oligomer names 
Oligomer names are derived from the names of their constituent protomers, separated by 
a hyphen, in alphabetic and numerical order (Fig.2), following the recommendations of 
[10]. By browsing “Oligomers”, users can scroll through a list of GPCR oligomers listed 
in alphabetical order using this nomenclature, with the organism in which they were 
characterized and the GPCR family name specified. When the same combination of 
protomers has been studied in different species, GPCR-OKB lists these combinations as 
different entries (for instance, the A2A-mGLU5 oligomer has been studied in both the rat 
and human organisms and appears as (at least) two entries.  
 
Oligomer categories 
Users can limit their oligomer search to a fewer oligomers by checking the following 
options in the search tool (Fig. 2): 
- "With Phenotypic Changes": users can limit their queries to retrieve only oligomers 
with demonstrated phenotypic changes with respect to the constituent protomers. For 
instance, these changes may refer to specific signaling or ligand recognition events. 
More detailed examples of these changes, and the description of the attributes used to 
characterize them for insertion into GPCR-OKB, have been reported previously in the 
literature [7]. 
- "With Proposed Interfaces": it restricts queries to retrieve only oligomers with 
published information about predicted interfaces of dimerization/oligomerization. 
- "With In Vivo Evidence": it limits the search to Oligomers for which at least one of 
the following conditions is satisfied: 1) Evidence for physical association in native 
tissue or primary cells; 2) Knowledge of specific functional properties in native 
tissue; and/or 3) Information from knockout animals or RNAi technology. These 
conditions are NC-IUPHAR recommendations to recognize a bona fide functional 
GPCR oligomer, according to a recent report published in the literature [11]. 
- "Evidence for Physiological Relevance": it limits the search to oligomers for which at 
least two of the aforementioned conditions are satisfied.  
Further cross-searches can be established by checking the “Find Protomer” and/or “Find 
Method” options. 
 
Protomers 
Protomers of oligomers stored in GPCR-OKB are also listed under “Browse” -> 
“Protomer”. No specific information about these protomers is stored in GPCR-OKB, but 
the database is linked to the latest release of GPCR-DB [9] for an easy access to updated 
information (e.g., sequences, alignments) about GPCR individual subunits, as described 
above. Protomers of oligomers can also be accessed by specifying the name of the 
constituent subunits of the oligomers in the input box of the search tool (Fig.2), and by 
checking the "Protomer" option. 
 
Methods 
The user can search the information contained in GPCR-OKB by specifying the 
computational/experimental procedures used to characterize/discover GPCR oligomers 
(i.e., the Methods). These include methods such as Fluorescence Resonance Energy 
Transfer (FRET), Bioluminescence Resonance Energy Transfer (BRET), Time Resolved 
FRET (TR-FRET), cross-linking, co-immunoprecipitation, Atomic Force Microscopy 
(AFM), and correlated mutation analysis. At the time of publication, GPCR-OKB 
includes information deriving from 14 different methods. 
 
Mechanisms of Activation 
GPCR-OKB also provides information in support of proposed activation mechanisms 
(e.g., trans- or cis-activation) of the oligomer. Specifically, where available in the 
literature, the user has access to information regarding structural changes upon oligomer 
activation, activating ligand, activated protomers, and/or GPCR/G protein stoichiometry.  
 
Discussion 
The information contained in GPCR-OKB, all linked to the corresponding original 
research papers, pertains specifically to GPCR oligomers. As such, the database is unique 
since there are no other available resources on GPCRs that provide the large amount of 
pharmacological, biophysical, and biochemical studies included into GPCR-OKB. Also 
unique to this system is the expert scrutiny that the information added to GPCR-OKB 
undergoes, given the quality control it receives by the scientific committee involved in 
the database development and population. Notably, the information chosen for inclusion 
into GPCR-OKB was tailored to the specific needs of experimental and computational 
investigators working in the GPCR oligomerization field.  Thus, GPCR-OKB is expected 
to be very useful to the scientific community as a whole. While specialized on GPCR 
oligomers, GPCR-OKB maintains bi-directional links with GPCR-DB that allow easy 
navigation to information about protomers as well as oligomers. 
We are aware of two other databases under development that provide information about 
GPCR oligomerization. The GRIP-DB system [12-13] is a mainly web-based facility that 
offers predictions about protein-protein interaction interfaces for GPCR oligomerization. 
The gpDB relationship database [14-15] also provides some information about GPCR 
oligomerization. However, it is mainly dedicated to disseminating and storing the 
knowledge pertaining to GPCR interactions with partner G-proteins and effector 
molecules. Despite its uniqueness in providing detailed information on GPCR oligomers 
verified by experts (e.g., effects of oligomer specific ligands, phenotypic changes, 
evidence for physiological/clinical relevance, proposed mechanisms of activation, etc.), 
GPCR-OKB was not designed to be a universal resource on GPCRs, but to interconnect 
with existing databases (e.g., GPCR-DB) to enhance its value.    
In the future, the GPCR-OKB will be updated on a regular basis to enrich the original 
dataset used for its first release in January 2010. As new information on GPCR oligomers 
emerges in the literature, it is possible that the relational scheme of GPCR-OKB will also 
need to be updated to offer better features to the users. The latter are encouraged to 
provide their feedback by email to help us implement improved future versions of GPCR-
OKB. 
Conclusions 
We present the GPCR-OKB system, a web-enabled knowledge base focused on GPCR 
oligomers. GPCR-OKB was designed for the benefit of the scientific community working 
in the GPCR field, and is intended to advance and disseminate knowledge on GPCR 
oligomerization. The information system, which is first of its kind, relies on a published 
ontological scheme that resulted from a community dialog between experimental and 
computational investigators working on GPCR oligomerization. GPCR-OKB builds on 
its ontology to integrate curated experimental and computational information about 
GPCR dimers/oligomers. The information is reported in an objective and neutral manner 
to encourage productive and substantiated communication among the domain experts. 
GPCR-OKB is expected to be very useful for molecular biologists conducting 
experiments, but will also benefit computational investigators interested in studying the 
implication of structure and dynamics of GPCR dimers/oligomers on receptor function. 
 
Availability and requirements 
GPCR-OKB is publically accessible at http://www.gpcr-okb.org. The system has been 
tested with a variety of web browsers and has no specific requirements. However, 
Internet Explorer version 7 and below are discouraged due to known problems with CSS 
layouts.  
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 Figure captions 
 
Figure 1. Types of information supported and navigation patterns. The main concept 
of GPCR-OKB is an Oligomer. Phenotypic Changes, Physiological Relevance, In vivo 
Evidence, Mechanisms of Activation, and Study, all are associated with each Oligomer. 
Oligomerization Interface and Methods concepts are linked to specific 
experimental/computational studies conducted on any given oligomer. 
 
Figure 2. Sample oligomer page at GPCR-OKB. A section of the webpage annotating 
5-HT2A–mGLU2 oligomer is illustrated alongside the different concepts associated with 
this oligomers (e.g., oligomer IUPHAR-approved and full names, Protomers, Studies, In 
vivo evidence, and Phenotypic Change). Additional concepts (not pictured) associated to 
each oligomer are Physiological Relevance and Mechanisms of Activation. 
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